Publications by authors named "Peter Boulos"

Claim this Profile
O
Outcomes After Noncardiac Surgery Performed Within 2 Years of Percutaneous Coronary Intervention.
Neel M Butala, Annika Hebbe, Binita Shah, Nathaniel R Smilowitz, Bilal Aijaz, Peter Boulos

J Am Heart Assoc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Outcomes of PCI Among Patients Ineligible for Surgical Revascularization in the Veterans Affairs Healthcare System.
Christopher P Kovach, Jerry Lipinski, Elise C Mesenbring, Peter Boulos, Abby Pribish

Circ Cardiovasc Interv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of COVID-19 With Common Cardiovascular Disorders.
Peter K Boulos, Scott V Freeman, Timothy D Henry, Ehtisham Mahmud, John C Messenger

Circ Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readmission After ACS: Burden, Epidemiology, and Mitigation.
Peter K Boulos, John C Messenger, Stephen W Waldo

Curr Cardiol Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"My Amazing Heart": A Patient's Simple Request to Change Outdated Heart Failure Labels.
Peter K Boulos, Gary Burgin, Rachel Johnson-Koenke, Kelsey M Flint

Circ Heart Fail· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The State of Hypertension in Sub-Saharan Africa: Review and Commentary.
Ayhan Yoruk, Peter K Boulos, John D Bisognano

Am J Hypertens· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Cortical Thickness Differences in Adolescent Females with Substance Use Disorders.
Peter K Boulos, Manish S Dalwani, Jody Tanabe, Susan K Mikulich-Gilbertson, Marie T Banich

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.
Konstantinos G Sidiropoulos, Qiang Ding, Georgios Pampalakis, Nicole M A White, Peter Boulos

Mol Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.
Konstantinos G Sidiropoulos, Nicole M A White, Anna Bui, Qiang Ding, Peter Boulos

Oncoscience· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment, despite a non-surgical approach, of severe infective endocarditis.
Peter K Boulos, Mark Y Jeong

BMJ Case Rep· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis